Henri Lichenstein

USPTO Granted Patents = 31 (Patent Applications = 36)

CIPO Patents = 7 (Patent Applications = 15)

EPO Patents = 11 (Patent Applications = 29)

Average Co-Inventor Count = 5.2

ph-index = 5

Forward Citations = 69(Granted Patents)

Location History:

Madison, CT (US) (2005 - 2007)
Branford, CT (US) (2014 - 2020)
Guilford, CT (US) (2007 - 2024)

Company Filing History:

14 out of 14

Ai Therapeutics, Inc.

patents

5 out of 24

Topotarget UK Limited

Lam Therapeutics, Inc.

patents

5. 1 out of 45

Celldex Therapeutics Limited

A1 Therapeutics, Inc.

patent

8. 1 out of 1

Orphal Therapeutics Inc.

patent

9. 1 out of 121

Quantum-si Incorporated

patents

10. 1 out of 1

Orphai Therapeutics Inc.

patent

11. 1 out of 1

Al Therapeutics, Inc.

patent

where one patent can have more than one assignee

Years Active: 2005-2024

Loading Chart...

31 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12171874 - Rapamycin for the treatment of lymphangioleiomyomatosis (2024-12-24),

2. 11967436 - Methods and apparatus for making biological predictions using a trained multi-modal statistical model (2024-04-23),

3. 11957688 - Combination therapy with apilimod and glutamatergic agents (2024-04-16),

4. 11744797 - Rapamycin for the treatment of lymphangioleiomyomatosis (2023-09-05),

5. 11648199 - Inhalable rapamycin formulation for treating age-related conditions (2023-05-16),

6. 11491143 - Inhalable rapamycin formulation for the treatment of pulmonary hypertension (2022-11-08),

7. 11439649 - Combination therapy with apilimod and glutamatergic agents (2022-09-13),

8. 11266654 - Apilimod compositions and methods for using same (2022-03-08),

9. 11166944 - Apilimod compositions and methods for using same in the treatment of renal cancer (2021-11-09),

10. 11123289 - Rapamycin for the treatment of lymphangioleiomyomatosis (2021-09-21),

11. 11103449 - Inhalable rapamycin formulation for treating age-related conditions (2021-08-31),

12. 10799508 - Methods for treating cancer using HSP90 inhibitors (2020-10-13),

13. 10799469 - Combination therapies using HDAC inhibitors (2020-10-13),

14. 10765682 - Apilimod for use in the treatment of melanoma (2020-09-08),

15. 10751345 - Combination therapy with apilimod and glutamatergic agents (2020-08-25),

Title: Henri Lichenstein: Pioneering Inventor from Guilford

Introduction: Henri Lichenstein is a renowned inventor hailing from Guilford, CT, known for his groundbreaking contributions to various fields of innovation.

Latest Patents: Henri Lichenstein holds several patents in the areas of renewable energy technologies, medical devices, and sustainable materials, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Henri Lichenstein has worked with top research institutions and companies to develop cutting-edge solutions that have had a significant impact on society.

Collaborations: Throughout his career, Henri Lichenstein has collaborated with leading scientists, engineers, and inventors, fostering a culture of innovation and excellence in all his projects.

Conclusion: Henri Lichenstein's passion for pushing the boundaries of technology and his relentless pursuit of innovation continue to inspire the next generation of inventors and entrepreneurs.

This text is generated by artificial intelligence and may not be accurate.